Literature DB >> 27427395

The importance of sustained attention in early Alzheimer's disease.

Jonathan D Huntley1, Adam Hampshire2, Daniel Bor3, Adrian M Owen4, Robert J Howard1.   

Abstract

INTRODUCTION: There is conflicting evidence regarding impairment of sustained attention in early Alzheimer's disease (AD). We examine whether sustained attention is impaired and predicts deficits in other cognitive domains in early AD.
METHODS: Fifty-one patients with early AD (MMSE > 18) and 15 healthy elderly controls were recruited. The sustained attention to response task (SART) was used to assess sustained attention. A subset of 25 patients also performed tasks assessing general cognitive function (ADAS-Cog), episodic memory (Logical memory scale, Paired Associates Learning), executive function (verbal fluency, grammatical reasoning) and working memory (digit and spatial span).
RESULTS: AD patients were significantly impaired on the SART compared to healthy controls (total error β = 19.75, p = 0.027). SART errors significantly correlated with MMSE score (Spearman's rho = -0.338, p = 0.015) and significantly predicted deficits in ADAS-Cog (β = 0.14, p = 0.004). DISCUSSIONS: Patients with early AD have significant deficits in sustained attention, as measured using the SART. This may impair performance on general cognitive testing, and therefore should be taken into account during clinical assessment, and everyday management of individuals with early AD.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer's disease; attention; cognition; neuropsychology

Mesh:

Year:  2016        PMID: 27427395     DOI: 10.1002/gps.4537

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  8 in total

1.  Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine.

Authors:  Charlotte Bakker; Jasper van der Aart; Ellen P Hart; Erica S Klaassen; Kirsten R Bergmann; Michiel J van Esdonk; Denis G Kay; Geert Jan Groeneveld
Journal:  Alzheimers Dement (N Y)       Date:  2020-10-13

2.  Measuring attention in rats with a visual signal detection task: Signal intensity vs. signal duration.

Authors:  Zade Holloway; Reese Koburov; Andrew Hawkey; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2020-11-02       Impact factor: 3.533

3.  Localization of Brain Networks Engaged by the Sustained Attention to Response Task Provides Quantitative Markers of Executive Impairment in Amyotrophic Lateral Sclerosis.

Authors:  Roisin McMackin; Stefan Dukic; Emmet Costello; Marta Pinto-Grau; Antonio Fasano; Teresa Buxo; Mark Heverin; Richard Reilly; Muthuraman Muthuraman; Niall Pender; Orla Hardiman; Bahman Nasseroleslami
Journal:  Cereb Cortex       Date:  2020-07-30       Impact factor: 5.357

Review 4.  Sleep and Attention in Alzheimer's Disease.

Authors:  Mirna Hennawy; Solomon Sabovich; Celina S Liu; Nathan Herrmann; Krista L Lanctôt
Journal:  Yale J Biol Med       Date:  2019-03-25

5.  Retention and impairment of neurocognitive functions in mild cognitive impairment and Alzheimer's disease with a comprehensive neuropsychological test.

Authors:  Lu Yao; Shinsuke Aoyama; Atushi Ouchi; Yasuji Yamamoto; Ichiro Sora
Journal:  Neuropsychopharmacol Rep       Date:  2022-03-05

6.  Evidence for a Specific Association Between Sustained Attention and Gait Speed in Middle-to-Older-Aged Adults.

Authors:  Hannah Park; Courtney Aul; Joseph DeGutis; On-Yee Lo; Victoria N Poole; Regina McGlinchey; Jonathan F Bean; Elizabeth Leritz; Michael Esterman
Journal:  Front Aging Neurosci       Date:  2021-07-05       Impact factor: 5.750

7.  Gait Variability Is Associated With the Strength of Functional Connectivity Between the Default and Dorsal Attention Brain Networks: Evidence From Multiple Cohorts.

Authors:  On-Yee Lo; Mark A Halko; Kathryn J Devaney; Peter M Wayne; Lewis A Lipsitz; Brad Manor
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-09-13       Impact factor: 6.591

Review 8.  Therapeutic Effects of Apamin as a Bee Venom Component for Non-Neoplastic Disease.

Authors:  Hyemin Gu; Sang Mi Han; Kwan-Kyu Park
Journal:  Toxins (Basel)       Date:  2020-03-19       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.